Right to participate. Registration
Shareholders who are registered in the register of shareholders maintained by
Shareholders whose shares are registered in the name of a nominee must, in order to be entitled to attend the meeting, request that their nominee re-register their shares in their own name, so that the shareholder is registered in the shareholder register on
Proxy
Shareholders who are represented by proxy shall issue a written, signed and dated power of attorney for the proxy. Shareholders should submit the power of attorney together with the notification of their intention to participate at the AGM. The expiry date of the proxy document may be no more than five years from its issue. Proxy forms are available on the company's website, https://investor.genovis.com/en/corporate-governance/general-meeting/. Representatives of legal entities must present a copy of the certificate of registration or equivalent authorization documents showing the authorized signatory.
Proposed Agenda
Opening of the Meeting.
Election of Chairman of the Meeting.
Preparation and approval of voting list.
Approval of the agenda.
Election of individuals to verify the minutes.
Consideration of whether the meeting had been duly convened.
Presentation of the annual report and the consolidated accounts as well as the audit report.
Speech by the Chief Executive Officer.
Resolutions on:
adoption of the Income Statement and the Balance Sheet, as well as the Consolidated Income Statement and the Consolidated Balance Sheet,
allocation of the Company's result in accordance with the adopted balance sheet,
discharge from liability to the company of the Directors and the Chief Executive Officer.
Resolution regarding number members of the Board and deputy members.
Resolution regarding directors' fees.
Election of Directors and Chairman of the Board.
Resolution on fees to auditors.
Election of auditor.
Appointment of members to the Nomination Committee and adoption of guidelines for the Nomination Committee
Resolution authorizing the Board of Directors to decide on the issuance of shares.
Authorization of the Chief Executive Officer to make such formal adjustments to the resolutions as may be necessary in conjunction with registration and implementation thereof.
Adjournment.
Item 2. Election of Chairman of the Meeting
The Nomination Committee proposes that attorney Arne Källén chair the meeting.
Item 10 Resolution regarding number of Board members and deputy members
The Nomination Committee proposes that the Board shall consist of five members without deputies.
Item 11 Determination of fees for members of the Board of Directors
The Nomination Committee proposes that fees until the close of the next Annual General Meeting shall be paid in the amount of
Item 12. Election of Directors and Chairman of the Board.
The Nomination Committee proposes:
Re-election of Board members
Re-election of
Item 13 Resolution on fees to auditors
The Nomination Committee proposes that remuneration to the auditors shall be paid on approved account.
Item 14 Election of auditor
The Nomination Committee proposes re-election of registered auditing firm Öhrlings
Item 15 Appointment of members to the Nomination Committee and adoption of guidelines for the Nomination Committee
The Nomination Committee proposes that the Committee for the 2025 AGM will consist of representatives of the four largest shareholders as of
The Nomination Committee proposes that remuneration will only be paid for direct costs associated with the assignment.
Item 16 The Board's proposal authorizing the Board of Directors to decide on the issuance of shares.
The Board proposes that the Meeting authorize the Board, on one or more occasions until the next Annual General Meeting, with or without preferential rights for shareholders, to issue new shares, convertible bonds or warrants. New shares may be paid for in cash and/or in kind or set-off or on other terms. This decision would mean that the share capital could be increased up to a maximum total of
shareholders, the subscription shall be market-based at the time of the issue resolution.
The reason for the possible deviation from shareholders' preferential rights is to broaden the ownership group, acquire, or facilitate the raising of working capital, increase the liquidity of shares, carry out acquisitions, or procure or permit the raising of capital for acquisitions.
For a valid resolution under this item, the Meeting's resolution must be supported by shareholders representing at least two thirds of both the voting rights and the shares represented at the Meeting.
Documents
The annual report, audit report, articles of association, proxy form and the other proposals for motions will be available at the Company's office at Karl Johans väg 104, Kävlinge, and on the Company's website www.genovis.com as of
Number of shares and votes
At the time of issuance of this notice, the total number of shares and votes in the company is 65,465,714.
Information at the Annual General Meeting
Shareholders are reminded of their right to request information from the Board of Directors and the Chief Executive Officer pursuant to Chapter 7, sections 32 and 57 of the Swedish Companies Act. A request for such information shall be submitted in writing to
Board of Directors
For more information, please contact:
The Group consists of
This is a translation of the Swedish original. In the event of any discrepancy between this translation and the Swedish original, the Swedish version shall prevail.
https://news.cision.com/genovis-ab/r/notice-convening-the-2024-annual-general-meeting,c3958589
https://mb.cision.com/Main/1712/3958589/2719399.pdf
(c) 2024 Cision. All rights reserved., source